Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy
Diabetes Care - United States
doi 10.2337/dc18-1343
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2019
Authors
Publisher
American Diabetes Association